Compare SRI & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRI | NAGE |
|---|---|---|
| Founded | 1965 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 212.8M |
| IPO Year | 1997 | 2010 |
| Metric | SRI | NAGE |
|---|---|---|
| Price | $6.22 | $2.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $12.08 |
| AVG Volume (30 Days) | 155.1K | ★ 470.4K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $824,444,000.00 | $129,423,000.00 |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | $2.90 | $16.67 |
| P/E Ratio | ★ N/A | $29.22 |
| Revenue Growth | 18.46 | ★ 29.95 |
| 52 Week Low | $4.60 | $2.60 |
| 52 Week High | $9.71 | $7.95 |
| Indicator | SRI | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 29.33 | 31.09 |
| Support Level | $6.14 | N/A |
| Resistance Level | $7.51 | $3.61 |
| Average True Range (ATR) | 0.22 | 0.10 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 4.40 | 12.50 |
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.